The pharma industry spent $57 million lobbying last year. And that’s just the start of its spending

As the public and politicians railed against high drug prices, the pharma industry aggressively ramped up its spending on lobbying, campaign donations, and ads.
Stephen Ubl, CEO of the drug industry trade group, at a White House meeting with President Trump in January. Source: Ron Sachs/Getty Images

Facing bipartisan hostility over high drug prices in an election year, the pharma industry’s biggest trade group boosted revenue by nearly a fourth last year and spread the millions collected among hundreds of lobbyists, politicians and patient groups, new filings show.

It was the biggest surge for the Pharmaceutical Research and Manufacturers of America, known as PhRMA, since the group took battle stations to advance its interests in 2009 during the run-up to the Affordable Care Act.

“Does that surprise you?” said Billy Tauzin, the former PhRMA CEO who ran the organization a decade ago as Obamacare loomed. Whenever Washington

You're reading a preview, sign up to read more.

More from STAT

STAT3 min readSociety
Opinion: Every American Should Wear A Face Mask To Defeat Covid-19
Let's go all-in against #Covid19 for the next eight weeks: a nationwide stay-at-home directive, ramp up face mask manufacturing capacity, and for now use makeshift face masks until ideal units…
STAT4 min read
A System To Allocate Scarce Ventilators And ICU Beds Gains Traction For Not Counting Any Group Out
Bracing for a surge of #Covid19 patients, hospitals and governments are grappling with an unimaginable question: If ventilators and intensive care unit beds must be rationed, who should get them?
STAT4 min read
A Nurse’s Coronavirus Routine: Recording Videos She Hopes Her Family Will Never Need To Watch
Anticipating a call to treat #coronavirus patients in the ICU, a Seattle nurse makes videos for her family — just in case she doesn't come home one day.